시장보고서
상품코드
1109457

세계의 원숭이두창 진단 시장 : 어세이별, 국가별, 제품별, 지역별 - 이그제큐티브 컨설턴트 가이드, 시장 분석과 예측(2022-2026년)

MONKEYPOX DIAGNOSTICS Global Markets by Assay, by Country, by Product, and by Place. With Executive and Consultant Guides and Market Analysis and Forecasts 2022 - 2026

발행일: | 리서치사: Howe Sound Research | 페이지 정보: 영문 294 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 원숭이두창 진단(Monkeypox Diagnostics) 시장에 대해 조사했으며, 시장 개요와 함께 어세이별, 국가별, 제품별, 장소별 동향 및 시장에 참여하는 기업 개요 등을 제공합니다.

목차

제1장 시장 가이드

제2장 서론과 시장 정의

  • 원숭이두창 진단 개요
    • 2022년 발생
  • 시장 정의
  • 조사 방법
  • 헬스케어와 체외진단 의약품 업계

제3장 원숭이두창 - 현재 과학

  • 원숭이두창란 무엇인가?
  • 발생
  • 감염
  • 징후와 증상
  • 진단
  • 치료
  • 원숭이두창과 천연두의 관계

제4장 업계 개요

  • 다이나믹 시장의 진출 기업
    • 학술연구기관
    • 진단 시험 개발업체
    • 의약품/시약 공급업체
    • 독립계 시험기관
    • 공공 국립/지역의 연구소
    • 원내 검사실
    • 진료소 검사실
    • 감사 기관
    • 인증 기관

제5장 시장 동향

  • 성장 촉진요인
  • 성장 저해요인
  • 진단 기술 개발

제6장 원숭이두창 진단 - 최근의 발전

제7장 주요 기업 개요

  • Abbott Diagnostics
  • Aegis Laboratories
  • Applied DNA Sciences
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • BioGX
  • bioMérieux Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Cepheid
  • CerTest Biotec
  • Creative Biogene
  • Flow Health
  • Labcorp
  • Mayo Clinic Laboratories
  • Quest Diagnostics
  • Qiagen Gmbh
  • Roche Molecular Diagnostics
  • Siemens Healthineers
  • Sonic Healthcare
  • Sysmex
  • Thermo Fisher Scientific Inc.

제8장 세계의 원숭이두창 진단 시장 개요

  • 국가별
  • 어세이별
  • 제품별
  • 장소별

제9장 세계의 원숭이두창 진단 시장 - 어세이별

  • PCR
  • NGS
  • 신속 시험
  • 기타 어세이
  • 바이오마커

제10장 세계의 원숭이두창 진단 시장 - 제품별

  • 장비
  • 소모품
  • 소프트웨어와 서비스

제11장 세계의 원숭이두창 진단 시장 - 장소별

  • 병원
  • 클리닉/POL
  • 기타

제12장 부록

KSM 22.08.12

OVERVIEW:

Monkeypox is being declared a health emergency. Latest data show the outbreak into non-African regions is expanding at alarming rates. Governments around the world are preparing to use widespread testing to get in front of this threat from the beginning. Opportunities abound for the In Vitro Diagnostic Industry.

The report forecasts the market size out to 2026. Growth is coming from the basic factors but the COVID Pandemic has changed to market landscape now and for the foreseeable future. Some players have already made their mark but disruptive diagnostic technology could change the playing field. Learn about this market including the issues and outlooks. The two key trends of Rapid Diagnostics and the Genomics Revolution are merging to create new diagnostic opportunities.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

  • 1.1. Situation Analysis
  • 1.2. Guide for Executives and Marketing Staff
  • 1.3. Guide for Investment Analysts and Management Consultants

2. Introduction and Market Definition

  • 2.1. An Overview of Monkeypox Diagnostics
    • 2.1.1. The 2022 Outbreak
  • 2.2. Market Definition
    • 2.2.1. Market Size
    • 2.2.2. Currency
    • 2.2.3. Years
    • 2.2.4. PCR
    • 2.2.5. NGS
    • 2.2.6. Syndromic PoC
    • 2.2.7. Biomarkers Molecular Diagnostics
    • 2.2.8. Biomarkers Other
    • 2.2.9. Limitations
  • 2.3. Methodology
    • 2.3.1. Methodology
    • 2.3.2. Sources
    • 2.3.3. Authors
  • 2.4. Healthcare and the IVD Industry
    • 2.4.1. Global Healthcare Spending
    • 2.4.2. Spending on Diagnostics
    • 2.4.3. Important Role of Insurance for Diagnostics

3. Monkeypox-Current Science

  • 3.1. What is Monkeypox?
  • 3.2. Outbreaks
  • 3.3. Transmission
  • 3.4. Signs and symptoms
  • 3.5. Diagnosis
  • 3.6. Therapeutics
    • 3.6.1. Vaccination
    • 3.6.2. Prevention
  • 3.6.2.1. Reducing the risk of human-to-human transmission
  • 3.6.2.2. Reducing the risk of zoonotic transmission
  • 3.7. How monkeypox relates to smallpox

4. Industry Overview

  • 4.1. Players in a Dynamic Market
    • 4.1.1. Academic Research Lab
    • 4.1.2. Diagnostic Test Developer
    • 4.1.3. Pharmaceutical/Reagent Supplier
    • 4.1.4. Independent Testing Lab
    • 4.1.5. Public National/regional lab
    • 4.1.6. Hospital lab
    • 4.1.7. Physician Lab
    • 4.1.8. Audit Body
    • 4.1.9. Certification Body

5. Market Trends

  • 5.1. Factors Driving Growth
    • 5.1.1. Prevalence
    • 5.1.2. Surveillance
    • 5.1.3. Pandemic Wind Down
    • 5.1.4. Viral Zeitqeist
  • 5.2. Factors Limiting Growth
    • 5.2.1. The Cost Curve Shrinks the Market
    • 5.2.2. Transmission Outlook
    • 5.2.3. Adoption Lag and Cost Control
  • 5.3. Diagnostic Technology Development
    • 5.3.1. The Multiplex Opportunity
    • 5.3.2. Shifting Role of Physicians in Diagnosis
    • 5.3.3. Diagnostics Moves Out of the Lab
    • 5.3.4. Biomarkers and Algorithms
    • 5.3.5. Rapid Testing Changing Medical Practice
    • 5.3.6. Genome Role and Big Data

6. Monkeypox Diagnostics - Recent Developments

  • 6.1. Recent Developments-Importance and How to Use This Section
    • 6.1.1. Importance of These Developments
    • 6.1.2. How to Use This Section
  • 6.2. U.S. to declare monkeypox a public health emergency
  • 6.3. BioGX Gets CE-IVD Mark for Multigene POC Test
  • 6.4. World Health Organization declares monkeypox a global emergency
  • 6.5. Quest Begins Offering Internally Developed Monkeypox Test
  • 6.6. CDC, Abbott, Roche, BioMérieux Get FDA 510(k) Clearances
  • 6.7. Commercial, Academic Labs Ramp Up Monkeypox Testing
  • 6.8. Becton Dickinson, CerTest Biotec Collaborate on Monkeypox MDx
  • 6.9. Sequence Coming In

7. Profiles of Key Companies

  • 7.1. Abbott Diagnostics
  • 7.2. Aegis Laboratories
  • 7.3. Applied DNA Sciences
  • 7.4. Beckman Coulter Diagnostics
  • 7.5. Becton, Dickinson and Company
  • 7.6. BioGX
  • 7.7. bioMérieux Diagnostics
  • 7.8. Bio-Rad Laboratories, Inc.
  • 7.9. Cepheid
  • 7.10. CerTest Biotec
  • 7.11. Creative Biogene
  • 7.12. Flow Health
  • 7.13. Labcorp
  • 7.14. Mayo Clinic Laboratories
  • 7.15. Quest Diagnostics
  • 7.16. Qiagen Gmbh
  • 7.17. Roche Molecular Diagnostics
  • 7.18. Siemens Healthineers
  • 7.19. Sonic Healthcare
  • 7.20. Sysmex
  • 7.21. Thermo Fisher Scientific Inc.

8. Monkeypox Global Diagnostic Markets Overview

  • 8.1. Monkeypox Diagnostics-Global Market Overview by Country
    • 8.1.1. Table-Global Market by Country
    • 8.1.2. Chart - Global Market by Country
  • 8.2. Global Monkeypox Diagnostics Markets Overview by Assay
    • 8.2.1. Table-Global Market by Assay
    • 8.2.2. Chart-Global Market by Assay-Segments Growth
    • 8.2.3. Chart-Global Market by Assay-Share by Year
    • 8.2.4. Chart-Global Market by Assay
    • 8.2.5. Chart-Global Market by Assay-Base Year
    • 8.2.6. Chart-Global Market by Assay-Final Year
  • 8.3. Global Monkeypox Diagnostics Markets Overview by Product
    • 8.3.1. Table-Global Market by Product
    • 8.3.2. Chart-Global Market by Product-Segments Growth
    • 8.3.3. Chart-Global Market by Product-Share by Year
    • 8.3.4. Chart-Global Market by Product
    • 8.3.5. Chart-Global Market by Product-Base Year
    • 8.3.6. Chart-Global Market by Product-Final Year
  • 8.4. Global Monkeypox Diagnostics Markets Overview by Place
    • 8.4.1. Table-Global Market by Place
    • 8.4.2. Chart-Global Market by Place-Segments Growth
    • 8.4.3. Chart-Global Market by Place-Share by Year
    • 8.4.4. Chart-Global Market by Place
    • 8.4.5. Chart-Global Market by Place-Base Year
    • 8.4.6. Chart-Global Market by Place-Final Year

9. Monkeypox Diagnostic Market-by Assay

  • 9.1. Monkeypox Diagnostic - PCR
    • 9.1.1. Table Monkeypox Diagnostic PCR-by Country
    • 9.1.2. Chart - Monkeypox Diagnostic PCR Growth
  • 9.2. Monkeypox Diagnostic-NGS
    • 9.2.1. Table Monkeypox Diagnostic NGS-by Country
    • 9.2.2. Chart - Monkeypox Diagnostic-NGS Growth
  • 9.3. Monkeypox Diagnostic-Rapid
    • 9.3.1. Table Monkeypox Diagnostic Rapid-by Country
    • 9.3.2. Chart - Monkeypox Diagnostic-Rapid Growth
  • 9.4. Monkeypox Diagnostic-Other Assay
    • 9.4.1. Table Monkeypox Diagnostic Other Assay-by Country
    • 9.4.2. Chart - Monkeypox Diagnostic-Other Assay Growth
  • 9.5. Monkeypox Diagnostic-Biomarker Other
    • 9.5.1. Table Monkeypox Diagnostic Biomarker Other-by Country
    • 9.5.2. Chart - Monkeypox Diagnostic-Biomarker Other Growth

10. Global Monkeypox Diagnostics Markets-By Product

  • 10.1. Monkeypox Diagnostic - Instrumentation
    • 10.1.1. Table Monkeypox Diagnostic Instrumentation-by Country
    • 10.1.2. Chart - Monkeypox Diagnostic Instrumentation Growth
  • 10.2. Monkeypox Diagnostic-Consumables
    • 10.2.1. Table Monkeypox Diagnostic Consumables-by Country
    • 10.2.2. Chart - Monkeypox Diagnostic Consumables
  • 10.3. Monkeypox Diagnostic-Software & Service
    • 10.3.1. Table Monkeypox Diagnostic Software & Service-by Country
    • 10.3.2. Chart - Monkeypox Diagnostic-Software & Service Growth

11. Global Monkeypox Diagnostics Markets-By Place

  • 11.1. Monkeypox Diagnostic - Hospital
    • 11.1.1. Table Monkeypox Diagnostic Hospital-by Country
    • 11.1.2. Chart - Monkeypox Diagnostic Hospital Growth
  • 11.2. Monkeypox Diagnostic-Clinic/POL
    • 11.2.1. Table Monkeypox Diagnostic Clinic/POL-by Country
    • 11.2.2. Chart - Monkeypox Diagnostic Clinic/POL Growth
  • 11.3. Monkeypox Diagnostic-Other Place
    • 11.3.1. Table Monkeypox Diagnostic Other Place-by Country
    • 11.3.2. Chart - Monkeypox Diagnostic Other Place

12. Appendices

  • 12.1. United States Medicare System: 2022 Clinical Laboratory Fees Schedule
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제